Company
B Braun Medical
Last checked: Nov 20, 2026Source: Drugs@FDA, ClinicalTrials.gov
NDAs and BLAs
4
4 still marketed
Novel approvals
0
Approvals since 2021
3
Originals and new uses
Phase 3 trials
1
Registered, any status
Trials by phase
All registered drug and biologic trials with this lead sponsor, any status. A public view of the pipeline.
Recent approvals
Originals and efficacy supplements, newest first.
- Rocuronium Bromide approved Oct 24, 2025
- Piperacillin and Tazobactam and Sodium Chloride In Duplex Container approved Apr 3, 2025
- Acetaminophen approved Feb 18, 2021
- Meropenem and Sodium Chloride In Duplex Container approved Apr 30, 2015
Drugs in development (0)
Investigational drugs, not yet FDA-approved, in this company's active or recent Phase 2 and 3 trials. Phase 3 first.
No investigational drugs in Phase 2 or 3 trials under this sponsor name.
Recruiting Phase 3 trials
Largest first.
No recruiting Phase 3 trials under this sponsor name.
Marketed drugs (4)
Newest FDA action first.
- Rocuronium Bromide Rocuronium Bromide · 2025
- Piperacillin and Tazobactam and Sodium Chloride In Duplex Container Piperacillin Sodium, Tazobactam Sodium · 2025
- Meropenem and Sodium Chloride In Duplex Container Meropenem · 2015
- Acetaminophen Acetaminophen · 2021
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.